Showing results (401-410 of 1,369) with videos related to
Sort By:
Pageof 137
Clinical and Experimental Immunology|April 27, 2010
The 'hygiene hypothesis' for autoimmune and allergic diseases: an updateH Okada, C Kuhn, H Feillet, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1994
[Early phase II clinical study of RP56976 (docetaxel) in patients with primary pulmonary cancer. Docetaxel Cooperative Study Group for Lung Cancer]A Yokoyama, Y Kurita, K Watanabe, et al.Cancer Chemotherapy and Pharmacology|January 27, 1998
Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II studyM Takada, S Negoro, S Kudo, et al.Cancer|January 1, 1996
Dose escalation study of carboplatin with fixed-dose etoposide plus granulocyte-colony stimulating factor in patients with small cell lung carcinoma. A study of the Lung Cancer Study Group of West JapanN Katakami, M Takada, S Negoro, et al.Developmental and Comparative Immunology|January 1, 1987
Blood type compatibility of lower vertebrates: phylogenetic diversity in blood transfusion between fish speciesD K Sakai, H Okada, N Koide, et al.Cell Death & Disease|December 2, 2011
HLA-B-associated transcript 3 (Bat3/Scythe) negatively regulates Smad phosphorylation in BMP signalingK Goto, K I Tong, J Ikura, et al.Research Communications in Molecular Pathology and Pharmacology|May 1, 1996
A phenomenological model describing pharyngeal pulsing in the nematode Caenorhabditis elegans anesthetized by alcoholS N Biswas, Y Ebina, H Okada, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 1996
[Late phase II study of LY188011 (gemcitabine hydrochloride) in patient with non-small-cell lung cancer. Gemcitabine Late Phase II Cooperative Study Group A)]M Fukuoka, S Negoro, S Kudo, et al.Cancer Research|January 1, 1985
Altered expression of cell surface membrane antigens in a common acute lymphoblastic leukemia-associated antigen-expressing neuroblastoma cell line (SJ-N-CG) with morphological differentiationT Sugimoto, T Sawada, S Negoro, et al.Gynecologic Oncology|December 22, 1999
Uterine pleomorphic rhabdomyosarcoma in a patient receiving tamoxifen therapyD H Okada, J B Rowland, L M PetrovicPageof 137